Global Molecular Diagnostics Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> - <strong>Global</strong><br />
Industry Analysis, Size, Share, Growth,<br />
Trends and Forecast 2017 - 2025<br />
The global molecular diagnostics market is highly consolidated in<br />
nature, observes Transparency <strong>Market</strong> Research. The leading players<br />
accounted for a share of 54% in the overall market in 2015. F. Hoffman-<br />
La Roche Ltd., Abbott Laboratories, and Danaher Corporation have<br />
dominated the global market in the past few years. The broad product<br />
portfolio and strategic mergers and acquisitions have been the winning<br />
strategies of these players to remain dominant.<br />
According to the research report, the global molecular diagnostic market<br />
is estimated to reach a valuation of US$18.9 bn by the end of 2025 as<br />
compared to US$7.1 bn in 2016. Between the forecast years of 2016 and<br />
2025, the global market is estimated to expand at a steady CAGR of<br />
11.6%.<br />
On the basis of technology, the global molecular diagnostics market is<br />
segmented into PCR and real-time PCR, hybridization, microarray,<br />
transcription-mediated amplification, next-generation sequencing, and<br />
others such as mass spectrometry. Of these, the PCR and real-time PCR<br />
technology segment is anticipated to show a significant progress during<br />
the forecast years.<br />
This segment is projected to expand at a CAGR of 11.1% between 2016<br />
and 2025. The extensive usage of this technology is expected to play<br />
significant role in its growth.
On the basis of geography, the global molecular diagnostics market is<br />
segmented into North America, Europe, Asia Pacific, the Middle East<br />
and Africa, and Latin America. Of these, North America is estimated to<br />
account for a share of 39.6% in the overall market by the end of 2025.<br />
This segment is likely to thrive due to the changing demographics, high<br />
prevalence of cancer, evolving lifestyles, and well-established healthcare<br />
infrastructure.<br />
Browse Full Research Report on <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>:<br />
http://www.transparencymarketresearch.com/molecular-diagnosticsindustry.html<br />
The global molecular diagnostic market is anticipated to be driven by the<br />
growing investments in research and development of biomarkers. The<br />
increasing uptake of biomarkers for diagnosis and prognosis as well as<br />
prediction and assessment of ongoing has augmented the demand for<br />
molecular diagnostics.<br />
Several kits designed for molecular diagnostics allow safe, quick, and<br />
accurate detection of infectious diseases such as HIV and hepatitis.<br />
Thus, the growing interest of big companies in expanding their business<br />
through developing biomarker solutions is expected to benefit the<br />
overall market.<br />
The continuous evolution in the field of molecular biology has changed<br />
the way diseases are being diagnosed and treated. The new methods<br />
have the ability to detect bacteria, viruses, and genetic variations in less<br />
time in with absolute precision. Thus, the upgrades in technology, which<br />
have significantly customized health care have boosted the demand for
molecular diagnostics in recent years. Analysts also predict that the wide<br />
range of technologies for diagnosis of diseases will give the global<br />
market a shot in the arm during the forecast period.<br />
The long lead time for FDA approvals for molecular diagnostics is<br />
severely restraining the growth of the global market. <strong>Molecular</strong><br />
diagnostics haven’t had a clinical impact on medical practice as was<br />
predicted earlier as delays in approvals have created potential hurdles.<br />
The market is also being hampered due to the poor reimbursement<br />
policies. The low awareness and lack of clarity pertaining to the<br />
diagnostic techniques used for detecting various injections and chronic<br />
conditions is a key challenge to the growth of the overall market.<br />
This review is based on Transparency <strong>Market</strong> Research, titled<br />
“<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> - <strong>Global</strong> Industry Analysis, Size, Share,<br />
Growth, Trends and Forecast, 2017-2025.”<br />
Browse Full Press Release on <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>:<br />
Press Release
About Us<br />
Transparency <strong>Market</strong> Research (TMR) is a global market intelligence<br />
company providing business information reports and services. The<br />
company’s exclusive blend of quantitative forecasting and trend analysis<br />
provides forward-looking insight for thousands of decision makers.<br />
TMR’s experienced team of analysts, researchers, and consultants use<br />
proprietary data sources and various tools and techniques to gather and<br />
analyze information.<br />
TMR’s data repository is continuously updated and revised by a team of<br />
research experts so that it always reflects the latest trends and<br />
information. With extensive research and analysis capabilities,<br />
Transparency <strong>Market</strong> Research employs rigorous primary and secondary<br />
research techniques to develop distinctive data sets and research material<br />
for business reports.<br />
Contact Us<br />
Transparency <strong>Market</strong> Research<br />
State Tower,<br />
90 State Street, Suite 700,<br />
Albany NY - 12207<br />
United States<br />
USA - Canada Toll Free: 866-552-3453<br />
Email: sales@transparencymarketresearch.com<br />
Website: http://www.transparencymarketresearch.com
Change language